Evidence-Based Medicine Guidelines
Teriflunomide for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Teriflunomide for Multiple Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/_________Teriflunomide_for_multiple_sclerosis______.
Teriflunomide for multiple sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/_________Teriflunomide_for_multiple_sclerosis______. Accessed November 21, 2024.
Teriflunomide for multiple sclerosis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/_________Teriflunomide_for_multiple_sclerosis______
Teriflunomide for Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/_________Teriflunomide_for_multiple_sclerosis______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Teriflunomide for multiple sclerosis
ID - 457724
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/_________Teriflunomide_for_multiple_sclerosis______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
